SOXX Options Hit Two-Sigma as Shorts Rebuild
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
SOXX has fallen another 8% this week to $500, and unlike last week's note, the short position is now moving back in line with the bearish options signal.
The most significant development is options positioning. Demand for downside protection has jumped to its most extreme level in months, with the put/call ratio at 2.06, more than two standard deviations above its 20-day average of 1.75. That is the highest PCR reading since the ratio spiked to 4.28 at its 52-week peak, and it marks a sharp deterioration from the 1.69 reading seen just two days ago on October 19. For context, last week's note flagged the PCR at 1.90 as "cautious but not extreme." This week's jump to 2.06 with a z-score of 2.16 pushes the signal well into territory where options traders are actively pressing on the downside.
Short interest has reversed the cover trade that defined last week's note. After bears cut positions sharply in the days following October 8, short interest has climbed back 4.2% on the week to 20.3% of float, around 11.4 million shares. That partially unwinds the retreat from the 24% levels that persisted through September, though the one-month picture still shows a net 12% decline from the peak. Borrowing costs have eased 11% on the week to 0.81%, suggesting new shorts are entering on easy terms. Availability has tightened somewhat, dropping from around 79% a week ago to 60.5% today, well above the 4.3% extreme seen in mid-September but moving in the direction of firmer borrow conditions. The lending market is snug rather than stressed.
What makes this week's setup more charged than last week's is the alignment of the two signals. The prior note described a divergence: short sellers were covering while options traders stayed cautious. That divergence has closed. Shorts are rebuilding and put buyers are stepping up simultaneously, putting both positioning signals on the same side of the trade as the fund drops through $500 for the first time in the recent leg down. The ORTEX short score is holding at 66.3, roughly where it has been for the past fortnight, consistent with a persistently elevated short pressure reading rather than a spike event.
The institutional ownership picture, last reported as of June 30, shows Goldman Sachs as the largest disclosed holder at 5.9% of shares, with Susquehanna building its position by 877,000 shares in the quarter. That Susquehanna move is notable given the firm's options market-making profile, it may reflect hedging flows rather than a directional bet. Healthcare of Ontario Pension added 640,000 shares in the same period, one of the larger conviction additions among the top holders. Holocene Advisors entered as a new holder with 760,000 shares. These June positions predate the current selloff and offer limited read-through to current sentiment.
The earnings history for SOXX is worth keeping in mind. The fund's most recent material price event came in June 2026, when it fell 12.3% in a single session. The five-day return from that event was a further 4.7% loss. Two prior events produced much smaller moves, with the December 2025 print generating a 1.1% gain on the day and a 4.5% gain over five days. With no next earnings date flagged, the key variable for the coming week is whether the sector data flow, particularly anything touching AI server demand or memory pricing, gives options traders reason to unwind their elevated put positions or press them further.
Stocks in this article
See the live data behind this article on ORTEX.
Open SOXX on ORTEX →How this article was generated
- Generated
- 21 Oct 2026, 19:21
- Data as of
- 21 Oct 2026, 19:18
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.